Document
IPR2024-00107, No. 1035 Exhibit - Lund, Emerging GLP 1 Receptor Agonists, 16 EXPERT OP ON EMERGING DRUGS 607 (P.T.A.B. Nov. 2, 2023)
Cite Document
IPR2024-00107, No. 1035 Exhibit - Lund, Emerging GLP 1 Receptor Agonists, 16 EXPERT OP ON EMERGING DRUGS 607 (P.T.A.B. Nov. 2, 2023)
+ More Snippets
Document
IPR2024-00107, No. 1043 Exhibit - US Patent App Pub 20040102486 (P.T.A.B. Nov. 2, 2023)
Cite Document
IPR2024-00107, No. 1043 Exhibit - US Patent App Pub 20040102486 (P.T.A.B. Nov. 2, 2023)
+ More Snippets
Document
IPR2024-00107, No. 1011 Exhibit - WO 2011138421 (P.T.A.B. Nov. 2, 2023)
Cite Document
IPR2024-00107, No. 1011 Exhibit - WO 2011138421 (P.T.A.B. Nov. 2, 2023)
+ More Snippets
Document
IPR2024-00107, No. 1013 Exhibit - Clinical Trial No NCT00696657 (P.T.A.B. Nov. 2, 2023)
Cite Document
IPR2024-00107, No. 1013 Exhibit - Clinical Trial No NCT00696657 (P.T.A.B. Nov. 2, 2023)
+ More Snippets
Document
IPR2024-00107, No. 1001 Exhibit - US Patent No 10,335,462 (P.T.A.B. Nov. 2, 2023)
Cite Document
IPR2024-00107, No. 1001 Exhibit - US Patent No 10,335,462 (P.T.A.B. Nov. 2, 2023)
+ More Snippets
Document
IPR2024-00107, No. 1029 Exhibit - Jimenez Solem, Dulaglutide, a Long Acting GLP 1 Analog Fused with an Fc Ant (P.T.A.B. Nov. 2, 2023)
Cite Document
IPR2024-00107, No. 1029 Exhibit - Jimenez Solem, Dulaglutide, a Long Acting GLP 1 Analog Fused with an Fc Ant (P.T.A.B. Nov. 2, 2023)
+ More Snippets
Document
IPR2024-00107, No. 1008 Exhibit - CV of Paul Dalby, PhD (P.T.A.B. Nov. 2, 2023)
Cite Document
IPR2024-00107, No. 1008 Exhibit - CV of Paul Dalby, PhD (P.T.A.B. Nov. 2, 2023)
+ More Snippets
Document
IPR2024-00107, No. 1037 Exhibit - Nielsen, Pharmacology of Exenatide Synthetic Exendin 4 A Potential Thera (P.T.A.B. Nov. 2, 2023)
Cite Document
IPR2024-00107, No. 1037 Exhibit - Nielsen, Pharmacology of Exenatide Synthetic Exendin 4 A Potential Thera (P.T.A.B. Nov. 2, 2023)
+ More Snippets
Document
IPR2024-00107, No. 1078 Exhibit - US Patent App Pub No 20040102486 (P.T.A.B. Nov. 2, 2023)
Cite Document
IPR2024-00107, No. 1078 Exhibit - US Patent App Pub No 20040102486 (P.T.A.B. Nov. 2, 2023)
+ More Snippets
Document
IPR2024-00107, No. 1005 Exhibit - Declaration of William J Jusko, PhD (P.T.A.B. Nov. 2, 2023)
Cite Document
IPR2024-00107, No. 1005 Exhibit - Declaration of William J Jusko, PhD (P.T.A.B. Nov. 2, 2023)
+ More Snippets
Document
IPR2024-00107, No. 1021 Exhibit - Byetta prescribing information Oct 2009 (P.T.A.B. Nov. 2, 2023)
Cite Document
IPR2024-00107, No. 1021 Exhibit - Byetta prescribing information Oct 2009 (P.T.A.B. Nov. 2, 2023)
+ More Snippets
Document
IPR2024-00107, No. 1004 Exhibit - CV of John Bantle MD (P.T.A.B. Nov. 2, 2023)
Cite Document
IPR2024-00107, No. 1004 Exhibit - CV of John Bantle MD (P.T.A.B. Nov. 2, 2023)
+ More Snippets
Document
IPR2024-00107, No. 1067 Exhibit - US Patent No 8,536,122 (P.T.A.B. Nov. 2, 2023)
Cite Document
IPR2024-00107, No. 1067 Exhibit - US Patent No 8,536,122 (P.T.A.B. Nov. 2, 2023)
+ More Snippets
Document
IPR2024-00107, No. 1074 Exhibit - WO 0037098 (P.T.A.B. Nov. 2, 2023)
Cite Document
IPR2024-00107, No. 1074 Exhibit - WO 0037098 (P.T.A.B. Nov. 2, 2023)
+ More Snippets
Document
IPR2024-00107, No. 1059 Exhibit - Murphy, Review of the Safety and Efficacy of Exenatide Once Weekly for the (P.T.A.B. Nov. 2, 2023)
Cite Document
IPR2024-00107, No. 1059 Exhibit - Murphy, Review of the Safety and Efficacy of Exenatide Once Weekly for the (P.T.A.B. Nov. 2, 2023)
+ More Snippets